Jianxia Wen

Prof. Dr. Jianxia Wen


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Phytomedicine
Verified
Journal Article
Closed access
JWJianxia Wen
Jianxia Wen
YTYu-Ling Tong
Yu-Ling Tong
XMXiao Ma
Xiao Ma
RWRui-Lin Wang
Rui-Lin Wang
RLRui-Sheng Li
Rui-Sheng Li
YZYanling Zhao
Yanling Zhao

5 February 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
XMXiao Ma
Xiao Ma
YJYinxiao Jiang
Yinxiao Jiang
WZWenwen Zhang
Wenwen Zhang
JWJiabo Wang
Jiabo Wang
RWRuilin Wang
Ruilin Wang
YZYanling Zhao
Yanling Zhao

14 September 2018 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
XMXiao Ma
Xiao Ma
JWJianxia Wen
Jianxia Wen
SGSi-Jia Gao
Si-Jia Gao
XHXuan He
Xuan He
PLPeng-Yan Li
Peng-Yan Li
XXXiao-He Xiao
Xiao-He Xiao

19 February 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
JWJianxia Wen
Jianxia Wen
LZLu Zhang
Lu Zhang
JWJian Wang
Jian Wang
JWJiabo Wang
Jiabo Wang
LWLifu Wang
Lifu Wang
YZYanling Zhao
Yanling Zhao
Higenamine (HG) is a natural benzylisoquinoline alkaloid isolated from Aconitum with positive inotropic and chronotropic effects. This study aimed to investigate the possible cardioprotective effects of HG combined with [6]‐gingerol (HG/[6]‐GR) against DOX‐induced chronic heart failure (CHF) by comprehensive approaches. DOX‐induced cardiotoxicity model in rats and H9c2 cells was established. Therapeutic effects of HG/[6]‐GR on haemodynamics, serum indices and histopathology of cardiac tissue were analysed. Cell mitochondrial energy phenotype and cell mitochondrial fuel flex were measured by a Seahorse XFp analyser. Moreover, UHPLC‐Q‐TOF/MS was performed to explore the potential metabolites affecting the therapeutic effects and pathological process of CHF. To further investigate the potential mechanism of HG/[6]‐GR, mRNA and protein expression levels of RAAS and LKB1/AMPK/Sirt1‐related pathways were detected. The present data demonstrated that the therapeutic effects of HG/[6]‐GR combination on CHF were presented in ameliorating heart function, down‐regulation serum indices and alleviating histological damage of heart tissue. Besides, HG/[6]‐GR has an effect on increasing cell viability of H9c2 cells, ameliorating DOX‐induced mitochondrial dysfunction and elevating mitochondrial OCR and ECAR value. Metabolomics analyses showed that the therapeutic effect of HG/[6]‐GR combination is mainly associated with the regulation of fatty acid metabolites and energy metabolism pathways. Furthermore, HG/[6]‐GR has an effect on down‐regulating RAAS pathway‐related molecules and up‐regulating LKB1/AMPKα/Sirt1‐related pathway. The present work demonstrates that HG/[6]‐GR prevented DOX‐induced cardiotoxicity via the cardiotonic effect and promoting myocardial energy metabolism through the LKB1/AMPKα/Sirt1 signalling pathway, which promotes mitochondrial energy metabolism and protects against CHF.


16 March 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JWJianxia Wen
Jianxia Wen
YYYi Yang
Yi Yang
JHJun-Jie Hao
Jun-Jie Hao
Acori Tatarinowii Rhizoma (ATR, Shi Chang Pu in Chinese), a natural product with multiple targets in various diseases. This review provides the comprehensive summary of the chemical composition, pharmacological effects, pharmacokinetics parameters and toxicity of ATR. The results indicated that ATR possesses a wide spectrum of chemical composition, including volatile oil, terpenoids, organic acids, flavonoids, amino acids, lignin, carbohydrates and so on. Accumulating evidence from various studies has shown that ATR exerts a wide range of pharmacological properties, including protecting nerve cells, alleviating learning and memory impairment, anti-ischemic, anti-myocardial ischemia, anti-arrhythmic, anti-tumor, anti-bacterial, and anti-oxidant activities. Currently, ATR is widely used in the central nervous system, cardiovascular system, gastrointestinal digestive system, respiratory system in China, and for the treatment of epilepsy, depression, amnesia, consciousness, anxiety, insomnia, aphasia, tinnitus, cancers, dementia, stroke, skin diseases, and other complex diseases. Pharmacokinetic studies indicated that β-asarone, α-asarone, cis-methylisoeugenol, and asarylaldehyde, the active components of ATR, were absorbed slowly after oral administration of ATR. Moreover, toxicity studies have suggested that ATR has no carcinogenic, teratogenic and mutagenic toxicity. Nevertheless, long term or high-dose toxicity testing in animals to explore the acute and chronic toxicity of acori Tatarinowii Rhizoma is still lacking. In view of good pharmacological activities, ATR is expected to be a potential drug candidate for the treatment of Alzheimer’s disease, depression, or ulcerative colitis. However, further studies are needed to elucidate its chemical composition, pharmacological effects, molecular mechanisms and targets, improve its oral bioavailability, and clarify its potential toxicity.